The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Gut microbiome composition to predict resistance in renal cell carcinoma (RCC) patients on nivolumab.
 
Lisa Derosa
Consulting or Advisory Role - Ipsen
 
Valerio Iebba
No Relationships to Disclose
 
Laurence Albiges
Consulting or Advisory Role - Amgen (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb; Bristol-Myers Squibb (Inst); Ipsen (Inst); Merck (Inst); Novartis; Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Marine Fidelle
No Relationships to Disclose
 
Melodie Bonvalet
No Relationships to Disclose
 
Emeline Colomba
No Relationships to Disclose
 
Laurence Zitvogel
Leadership - EverImmune
Honoraria - Lytix Biopharma; Transgene
Consulting or Advisory Role - Incyte; Lytix Biopharma
Research Funding - Lytix Biopharma; Roche; Transgene
Patents, Royalties, Other Intellectual Property - EverImmune
 
Bernard Escudier
Honoraria - Bayer; Bristol-Myers Squibb; Exelixis; Ipsen; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; EUSA Pharma; Exelixis; Ipsen; Novartis; Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pfizer
 
Bertrand Routy
Consulting or Advisory Role - Bristol-Myers Squibb